Literature DB >> 29967016

Predictors of Peripherally Inserted Central Catheter Occlusion in the Outpatient Parenteral Antimicrobial Therapy Setting.

Philip W Lam1, Christopher Graham2, Jerome A Leis1,3,4, Nick Daneman5,3.   

Abstract

In this retrospective study of 285 patients receiving outpatient parenteral antibiotic therapy (OPAT), the duration of antibiotic, use of double-lumen catheters, and receipt of penicillin G and cloxacillin appeared to increase the risk of peripherally inserted central catheter (PICC) occlusion. Physicians should consider these factors when prescribing long-term antibiotic therapy. Further studies are needed to evaluate methods to reduce PICC occlusion, particularly when double-lumen PICCs are necessary and when cloxacillin or penicillin G are the preferred treatment.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  occlusion; outpatient parenteral antimicrobial therapy; peripherally inserted central catheter

Mesh:

Substances:

Year:  2018        PMID: 29967016      PMCID: PMC6125544          DOI: 10.1128/AAC.00900-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Insertion of PICCs with minimum number of lumens reduces complications and costs.

Authors:  Jeremy O'Brien; France Paquet; Richard Lindsay; David Valenti
Journal:  J Am Coll Radiol       Date:  2013-09-26       Impact factor: 5.532

2.  Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.

Authors:  Kevin A Brown; Nagham Khanafer; Nick Daneman; David N Fisman
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

3.  Improving PICC use and outcomes in hospitalised patients: an interrupted time series study using MAGIC criteria.

Authors:  Lakshmi Swaminathan; Scott Flanders; Mary Rogers; Yvonne Calleja; Ashley Snyder; Rama Thyagarajan; Priscila Bercea; Vineet Chopra
Journal:  BMJ Qual Saf       Date:  2017-11-13       Impact factor: 7.035

4.  Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.

Authors:  Ilan Youngster; Erica S Shenoy; David C Hooper; Sandra B Nelson
Journal:  Clin Infect Dis       Date:  2014-04-29       Impact factor: 9.079

5.  Patterns and Predictors of Peripherally Inserted Central Catheter Occlusion: The 3P-O Study.

Authors:  Shawna N Smith; Nancy Moureau; Valerie M Vaughn; Tanya Boldenow; Scott Kaatz; Paul J Grant; Steven J Bernstein; Scott A Flanders; Vineet Chopra
Journal:  J Vasc Interv Radiol       Date:  2017-03-11       Impact factor: 3.464

6.  Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.

Authors:  Julius Li; Kelly L Echevarria; Darrel W Hughes; Jose A Cadena; Jason E Bowling; James S Lewis
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

7.  Central venous catheters in home infusion care: outcomes analysis in 50,470 patients.

Authors:  Nancy Moureau; Susan Poole; Margie A Murdock; Sarah M Gray; Charles P Semba
Journal:  J Vasc Interv Radiol       Date:  2002-10       Impact factor: 3.464

8.  Impact of Defaulting to Single-Lumen Peripherally Inserted Central Catheters on Patient Outcomes: An Interrupted Time Series Study.

Authors:  Philip W Lam; Cheryl Volling; Tiffany Chan; J Bradley Wiggers; Lucas Castellani; Julie Wright; Kenneth Peckham; Steven Shadowitz; Stephen Tasker; Derek R MacFadden; Nick Daneman; Wayne L Gold; Robyn Pugash; Jerome A Leis
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

  8 in total
  1 in total

Review 1.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.